Pharmaceutical firm Immunomedics reported first-quarter revenue of $4 million, up from $2 million in the first quarter of fiscal 2001. For the period (end-September 30), the Morris Plains, NJ-based vendor had a net loss of $182,000, compared with a net loss of $1.5 million in the same quarter a year ago. Immunomedics attributed the decreased loss to higher revenues from its licensing agreement with Amgen.
By AuntMinnie.com staff writersNovember 9, 2001
Related Reading
Immunomedics licenses labeling method, October 29, 2001
Immunomedics trims loss in 2001, August 8, 2001
Immunomedics appoints Sullivan CEO, March 21, 2001
Copyright © 2001AuntMinnie.com
